CROI 2020 Abstract eBook

Abstract eBook

Disclosure Index

DISCLOSURE OF FINANCIAL RELATIONSHIPS WITH COMMERCIAL CONCERNS Disclosure information is presented generally as submitted by the corresponding presenting abstract author, invited speaker, session moderator, or member of the CROI Program Committee as of February 24, 2020. The individuals below provided their relevant disclosures of financial relationships with commercial entities for themselves and their spouses or partners, as well as funding provided to their institutions on their behalf (eg, for research where they are the principal investigator). Updates to disclosures will be posted in the Abstract eBook on the CROI website. The Accreditation Council for Continuing Medical Education (ACCME) defines a financial interest as an interest in any amount and defines a commercial interest as “any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.” The information is intended to make the audience aware of speaker and contributor interests and commitments with commercial interests, enabling the audience members to form their own judgments about such associations.t

Acosta, Rima, K. Self: Employment Gilead Sciences, Inc, Stock/stock options Gilead Sciences, Inc Adimora, Adora Self: Advisory boards, consultant, research funding, educational conference development from Merck, Gilead Sciences, Inc, ViiV Healthcare Allavena, Clotilde Self: Board membership ViiV Healthcare and Janssen Alter, Galit Self: Consulting or advisor fees Seromyx To self, paid to my institution: Research grant/ grants pending from BioProtection Systems/New Link Genetics, Gilead Sciences, Merck Sanofi, Curevac, Janssen Therapeutics, GSK, Pfizer, BMS Althoff, Keri N. Self: Consulting or advisor fees TrioHealth Inc. Alvarez, Angeles To self, paid to my institution: Research grant/grant pending Gilead Sciences, Inc Anderson, Peter L. Self: Consulting or advisor fees Gilead Sciences To self, paid to my institution: Research grant/grant pending Gilead Sciences, Inc Andreatta, Kristen Self: Stock/stock options Gilead Sciences, Inc Andrieux-Meyer, Isabelle Self: Research grant/grant pending EDCTP Antinori, Andrea To self, paid to my institution: Consulting or advisor fees Gilead Sciences, Inc, ViiV Healthcare, Janssen-Cilag, Merck & Co, Inc Research grant/grant pending Gilead Sciences, Inc, ViiV Healthcare, Janssen-Cilag Aronson, Naomi, E. Self: Royalties UpToDate, Elsevier Averitt, Dawn Self: Advisor for Merck Balagopal, Ashwin Self: Consulting or advisor fees Gilead Sciences, Inc Barouch, Dan Self: Research grant/grant pending Gilead Sciences, Inc, Janssen Therapeutics, Legend Biotech. Patents from Janssen Begley, Rebecca Self: Employment Gilead Sciences, Inc Bekerman, Elena Self: Employment Gilead Sciences Inc.

Benson, Constance, A. To self, paid to my institution: Research grant Gilead Sciences, Inc. Data and Safety monitoring board GlaxoSmithKline/ViiV Healthcare Spouse or Partner: Consultant for CytoDyn. Board member, Gilead Sciences, Inc. Royalties from CytoDyn and Antiva Spouse or Partner, paid to institution: Honoraria for board membership Gilead Sciences, Inc. Data monitoring board honoraria Gilead Sciences, Inc, VIR Berenguer, Juan To self, paid to my institution: Consulting or advisor fees Gilead Sciences, Inc, Janssen Therapeutics, MSD, ViiV Healthcare. Research grant/grant pending MSD, ViiV Healthcare Beyrer, Chris Self: Donation of study drugs from Gilead Sciences, Inc Blumenthal, Jill Provision of medicine or equipment Gilead Borghetti, Alberto Self: Board membership ViiV Healthcare Boulware, David R. Self: Provision of medicine or equipment Matinas Bourgi, Kassem To self, paid to my institution: Research grant/grant pending Gilead Sciences Brew, Bruce, J. To self, paid to my institution: Consulting or advisor fees AbbVie, ViiV Healthcare, MSD, Boehringer Ingelheim, Biogen Idec, Novartis. Research grant/grant pending from AbbVie, ViiV Healthcare. Speaker's bureau ViiV Healthcare, Novartis, Biogen Idec, Boehringer Ingelheim Brook, Gary Self: Research grant/grant pending Diagnostics for the Real World (DRW) Ltd Buchbinder, Susan, P. Self: Donated research materials from Gilead Sciences, Inc Burwitz, Benjamin J. Self: Research grant/grant pending Vir Biotechnology Busch, Michael P. Self: Research grant/grant pending Hologic Butt, Adeel A. Self: Research grant/grant pending Gilead Sciences, Inc Buzón, María J. Self: Research grant/grant pending Gilead Sciences, Inc Cachay, Edward R. Self: Consulting or advisor fees Gilead Sciences, Inc

Calcagno, Andrea To self, paid to my institution: Consulting or advisor fees Janssen-Cilag, ViiV Healthcare Self: Research grant/grant pending ViiV Healthcare, Gilead Sciences, Inc Other MSD, Janssen-Cilag, ViiV Healthcare, Gilead Sciences, Inc Capeau, Jacqueline Self: Research grant/grant pending ViiV Healthcare MSD. Other fees for academic presentation during workshops ViiV Healthcare, MSD, Gilead Sciences, Inc, Janssen Cespedes, Michelle S. Self: Research grant/grant pending Gilead Sciences, Inc, Glaxo-Smith-Kline/ViiV Healthcare Consulting or advisor fees Gilead Sciences Chang, Larry W. Self: Stock/stock options emocha Mobile Health Inc Chaisson, Richard, E. Self: Speaking fee and travel reimbursement Janssen. Consultant for Sanofi Spouse or Partner: Stockholder in Merck Chaturvedula, Ayyappa Self: Consulting or advisor fees Global Pharmaceutical Advisors, LLC Chen, Zhijian (James) Self: Research grant/grant pending ImmuneSensor Chéret, Antoine To self, paid to my institution: Research grant/grant pending Merck & Co, Inc, Janssen Therapeutics, ViiV Healthcare, Gilead Sciences, Inc Chomont, Nicolas Self: Consultant EMD Serono, Gilead Sciences, Inc To self, paid to my institution: Research grants EMD Serono, Gilead Sciences, Inc Chung, Raymond T. To self, paid to my institution: Research grant/grant pending Gilead Sciences, Inc, BMS, Janssen Therapeutics, Boehringer Ingelheim, Roche Churchyard, Gavin To self, paid to my institution: Provision of medicine or equipment Sanofi Coffin, John M. Self: Shareholder Tocagen. Scientific advisory board

Disclosure Information

ROME Therapeutics Colbers, Angela

To self, paid to my institution: Research grant/grant pending Merck Sharp & Dohme, Gilead Sciences, Inc ViiV Healthcare

CROI 2020 434